Keisuke Nagasaki

Dr. Keisuke Nagasaki

Niigata University Graduate School of Medical and Dental Sciences
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2004 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
NSNaoko Sato
Naoko Sato
NKNoriyuki Katsumata
Noriyuki Katsumata
MKMasayo Kagami
Masayo Kagami
THTomonobu Hasegawa
Tomonobu Hasegawa
NHNaoaki Hori
Naoaki Hori
TOTsutomu Ogata
Tsutomu Ogata
We report on the clinical and molecular findings in 25 males and three females with Kallmann syndrome (KS) aged 10–53 yr. Ten males were from five families, and the remaining 15 males and three females were apparently sporadic cases. Molecular studies were performed for Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, also known as KAL2) by sequence analysis for all the coding exons, by PCR-based deletion analysis, and by fluorescence in situ hybridization (FISH) analysis, showing six novel and two recurrent intragenic KAL1 mutations in seven familial and four sporadic male cases and two novel intragenic FGFR1 mutations in two sporadic male cases. In addition, submicroscopic deletions at Xp22.3 involving VCX-A, STS, KAL1, and OA1 were identified in three familial cases and one sporadic male case affected by a contiguous gene syndrome. Clinical assessment in the 15 males with KAL1 mutations showed normal and borderline olfactory function in two males and right-side dominant renal lesion in seven males, in addition to variable degrees of hypogonadotropic hypogonadism (HH) in all the 15 males and olfactory dysfunction in 13 males. The two males with FGFR1 mutations had HH and anosmia and lacked other features. Clinical features in the remaining 11 cases with no demonstrable KAL1 or FGFR1 mutations included right renal aplasia in one female, cleft palate in one male, cleft palate and perceptive deafness in one male, and dental agenesis and perceptive deafness in one male, in addition to a variable extent of HH and olfactory dysfunction. The results suggest the following: 1) KAL1 mutations might be more prevalent in the Japanese patients than previously estimated in the Caucasian patients and can be associated with apparently normal olfactory function; 2) FGFR1 mutations account for approximately 10% of KS patients, as previously reported in the Caucasian patients, and can result in HH and olfactory dysfunction-only phenotype; and 3) renal aplasia, which is characteristic of KAL1 mutations, and cleft palate and dental agenesis, which are characteristic of FGFR1 mutations, can occur in patients without KAL1 and FGFR1 mutations.

1 December 2017 in Genetics in Medicine
Verified
Journal Article
Open access
PDF file
MKMasayo Kagami
Masayo Kagami
Keisuke NagasakiKeisuke Nagasaki
Keisuke Nagasaki
RKRika Kosaki
Rika Kosaki
RHReiko Horikawa
Reiko Horikawa
YNYasuhiro Naiki
Yasuhiro Naiki
TOTsutomu Ogata
Tsutomu Ogata
Temple syndrome (TS14) is a rare imprinting disorder caused by aberrations at the 14q32.2 imprinted region. Here, we report comprehensive molecular and clinical findings in 32 Japanese patients with TS14. We performed molecular studies for TS14 in 356 patients with variable phenotypes, and clinical studies in all TS14 patients, including 13 previously reported. We identified 19 new patients with TS14, and the total of 32 patients was made up of 23 patients with maternal uniparental disomy (UPD(14)mat), six patients with epimutations, and three patients with microdeletions. Clinical studies revealed both Prader-Willi syndrome (PWS)-like marked hypotonia and Silver-Russell syndrome (SRS)-like phenotype in 50% of patients, PWS-like hypotonia alone in 20% of patients, SRS-like phenotype alone in 20% of patients, and nonsyndromic growth failure in the remaining 10% of patients in infancy, and gonadotropin-dependent precocious puberty in 76% of patients who were pubescent or older. These results suggest that TS14 is not only a genetically diagnosed entity but also a clinically recognizable disorder. Genetic testing for TS14 should be considered in patients with growth failure plus both PWS-like hypotonia and SRS-like phenotypes in infancy, and/or precocious puberty, as well as a familial history of Kagami-Ogata syndrome due to maternal microdeletion at 14q32.2.

27 October 2018 in Human Genetics
Verified
Journal Article
Closed access
PDF file
IUIkumi Umeki
Ikumi Umeki
TNTetsuya Niihori
Tetsuya Niihori
TATaiki Abe
Taiki Abe
SKShin-Ichiro Kanno
Shin-Ichiro Kanno
NONobuhiko Okamoto
Nobuhiko Okamoto
YAYoko Aoki
Yoko Aoki

1 January 2010 in World Journal of Gastroenterology
Verified
Journal Article
Open access
AOAkihiko Osaki
Akihiko Osaki
TKTomoyuki Kubota
Tomoyuki Kubota
TSTakeshi Suda
Takeshi Suda
MIMasato Igarashi
Masato Igarashi
Keisuke NagasakiKeisuke Nagasaki
Keisuke Nagasaki
YAYutaka Aoyagi
Yutaka Aoyagi
AIM: To investigate whether a noninvasive measurement of tissue strain has a potential usefulness for management of nonalcoholic steatohepatitis (NASH).

4 April 2017 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
TKTaichi Kitaoka
Taichi Kitaoka
TTToshihiro Tajima
Toshihiro Tajima
Keisuke NagasakiKeisuke Nagasaki
Keisuke Nagasaki
TKToru Kikuchi
Toru Kikuchi
KYKatsusuke Yamamoto
Katsusuke Yamamoto
KOKeiichi Ozono
Keiichi Ozono

17 September 2019 in Journal of Human Genetics
Verified
Journal Article
Closed access
PDF file
FSFutoshi Sekiguchi
Futoshi Sekiguchi
YTYoshinori Tsurusaki
Yoshinori Tsurusaki
NONobuhiko Okamoto
Nobuhiko Okamoto
KTKeng Wee Teik
Keng Wee Teik
SMSeiji Mizuno
Seiji Mizuno
NMNaomichi Matsumoto
Naomichi Matsumoto